# Tchéquie – Immunosuppresseurs – Imunosupresiva inhibitory TNF alfa Infliximab s.c. podání II. (dále také jen “zakázka” nebo „VZ“)

Acheteur : Institut klinické a experimentální medicíny.  Pays : Tchéquie.  CPV : 33652300.

Source: QUOTA CÔTE — https://quotacote.com/opportunites/tchequie-immunosuppresseurs-imunosupresiva-inhibitory-tnf-alfa-inflixi--2333cb03-607a-4d58-8efe-07e0d104a060
Last checked by QUOTA: 2026-08-31
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Tchéquie [FACT]
- Deadline: 2026-09-10 [FACT]
- Last checked by QUOTA: 2026-08-31 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Tchéquie
- funder: Institut klinické a experimentální medicíny
- buyer: Institut klinické a experimentální medicíny

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.